; (B) the International Agency for Research on Cancer; (C) the National Institutes of Health; (D) the California Environmental Protection Agency; and (E) any other authoritative international, Federal, or State entity, as determined by the Secretary. 616. Lists of ingredients and required responses (a) Placement on list (1) In general Based on an initial review and evaluation of the chronic health impacts associated with an ingredient that is used in one or more cosmetics, the Secretary shall create and periodically update a list of ingredients for safety review. From such list, the Secretary shall place ingredients on a priority assessment list and, after comprehensive safety review, place each ingredient on the priority assessment list on one of the following lists: (A) The prohibited and restricted lists under subsection (b). (B) The safe without limits list under subsection (c). (C) The insufficient data list under subsection (d). (2) Initial list The Secretary shall add 20 ingredients to the initial priority assessment list created under paragraph (1) immediately after the enactment of this subchapter. (3) Considerations In determining the placement of an ingredient on the priority assessment list under paragraph (1), the Secretary shall consider the scientific evidence linking that ingredient to harm and conduct further prioritization based on whether the ingredient— (A) is found to be present in the body through biomonitoring; (B) is found in drinking water or air; (C) is a known or suspected neurological or immunological toxicant, respiratory asthmagen, carcinogen, teratogen, or endocrine disruptor, or have other toxicity concerns (including reproductive or developmental toxicity); (D) is known to persist in the environment or bioaccumulate